https://orcid.org/0000-0002-3073-2830
References
- Camacho Moreno G, Imbachi LF, Leal AL, Moreno VM, Patino JA, Gutierrez IF, Beltran S, Alvarez-Olmos MI, Marino C, Barrero R, et al. Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogotá, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10. Hum Vaccin Immunother. 2020;1–7. doi:10.1080/21645515.2019.1710411.
- Rojas JP, Leal AL, Patino J, Montanez A, Camacho G, Beltran S, Bonilla C, Barrero R, Marino C, Ramos N, et al. [Characterization of patients who died of invasive pneumococcal disease in the child population of Bogota, Colombia]. Rev Chil Pediatr. 2016;87(1):48–52. doi:10.1016/j.rchipe.2015.10.005.
- de Oliveira LH, Camacho LA, Coutinho ES, Martinez-Silveira MS, Carvalho AF, Ruiz-Matus C, Toscano CM. Impact and effectiveness of 10 and 13-valent pneumococcal conjugate vaccines on hospitalization and mortality in children aged less than 5 years in Latin American countries: A systematic review. PLoS One. 2016;11(12):e0166736. doi:10.1371/journal.pone.0166736.
- Izurieta P, Bahety P, Adegbola R, Clarke C, Hoet B. Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution. Expert Rev Vaccines. 2018;17(6):479–93. doi:10.1080/14760584.2018.1413354.
- World Health Organization. Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper – February 2019. Wkly Epidemiol Rec. 2019;94(8):85–104.
- Pan American Health Organization. Technical advisory group on vaccine-preventable diseases (TAG). XXIV meeting. 12-14 July, 2017. Panama, Panama City; 2017
- Caceres D, DeAntonio R, Nieto J, Gomez J. Estimated annual impact of pneumococcal conjugate vaccine (PCV) immunization program in Colombia (2011-2018). Presented at ISPOR Latin America, Bogotá, Colombia, 12-14 September 2019.
- Gomez JA, Lopes de Abreu AJ, Caceres DC, Nieto J, Ortega-Barria E. Estimated annual health and cost impact of PHiD-CV immunization program in Brazil. Pediatr Infect Dis J. 2019;38(10):e260–e265. doi:10.1097/INF.0000000000002436.